Jess is a European and UK qualified patent attorney in the Life Sciences team at Kilburn & Strode. 
 
Jess specialises in the fields of T-cell engineering, RNA-based therapies, and antibodies. Jess also has significant experience advising clients in the fast-moving food tech industry. Despite moving on from her academic career, Jess maintains a special interest in therapies for neurodegenerative diseases, having previously worked as a postdoctoral research fellow in this field at the University of Edinburgh.
 
With a reputation for friendly and pragmatic advice, Jess enjoys providing tailored advice on IP strategy, be it for start-ups looking for guidance across the spectrum of IP, or for multinational pharmaceutical clients coordinating complex patent filing strategies. Jess also has a strong practice in EPO oppositions, having acted for a variety of clients in the diagnostics, biologics, and manufacturing fields.
 
Jess is also keenly interested in how biotechnology can be used to address climate change, and the innovative solutions that the Life Sciences industry can offer to improve sustainability and lessen our reliance on fossil fuels.
 
Jess holds a PhD in Neuroscience and has authored numerous academic papers, with her research highlighting the contribution of oxidative stress and glial cell activation to neurodegeneration in vascular dementia.

Qualifications

European Patent Attorney 
Chartered UK Patent Attorney 
Representative before the Unified Patent Court (UPC) (2023)
PhD in Neuroscience – University of Edinburgh (2017)
MSc in Integrative Neuroscience – University of Edinburgh (2013)
BSc in Neuroscience and Psychology – University of Manchester (2011)

Memberships

Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept